The global clonorchiasis market is expected to grow at a CAGR
of 5.4% during the forecast period.
Clonorchiasis is an infectious disease caused by the
Chinese liver fluke Clonorchis
sinensis. Clonorchiasis is dominant in Asian countries and regions,
including South Korea, China, Northern Vietnam, and far-eastern Russia. China
has the largest population of infected people. In the acute phase, heavier
infections can cause fever, chills, epigastric pain, tender hepatomegaly, mild
jaundice, and eosinophilia occur. Chronic cholangitis in heavy infections,
which may progress to atrophy of liver parenchyma, portal fibrosis, and
cirrhosis. Increasing prevalence of clonorchiasis, changing lifestyle, poor
diet, and increasing geriatric population have driven the growth of the market.
Moreover, increasing healthcare expenditure has fuelled the growth of the
market. On the other hand, high cost of the treatment may slow the market
growth.
Market Key Players
The key players for the global clonorchiasis market are Pfizer
(U.S), Bayer AG (Germany), Provet (Switzerland), Virbac (India), Cipla (India),
Novartis AG (Switzerland), CIRON Drugs & Pharmaceuticals Pvt. Ltd. (India),
Merck & Co., Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Abbott
(U.S.), Arsanis, Inc. (Austria), Novabiotics (U.K.), GlaxoSmithKline plc.
(U.K.), and Teva Pharmaceutical Industries Ltd (Taiwan).
Market Segmentation
The global clonorchiasis
market is segmented on the basis of parasites, therapy, and end users.
On the basis of the parasites, the market is segmented into
Clonorchis sinensis,
Opisthorchis viverrini, Opisthorchis felineus, and others.
On the basis of the therapy, the market is segmented into
diagnosis and treatment. The diagnosis is further segmented into microscopic
examination, X-ray, serologic tests, and others. The treatment is sub-segmented
into praziquantel, cesol, cisticid, biltricide, and others.
On the basis of end users, the market is segmented into
hospital, clinics, and others.
Access Complete Details Here: https://www.marketresearchfuture.com/reports/clonorchiasis-market-4686
Regional Analysis
The Americas dominate the
global clonorchiasis market owing to a large geriatric population, strong
government support for research & development, and high healthcare
spending. According to the Centers for Disease Control and Prevention in 2014,
over 14.8 million of the U.S. population had GI diseases. Increasing prevalence
of GI diseases has boosted the market growth. Additionally, poor diet and
increasing awareness has fuelled the growth of the market.
Europe is the second leading market across the globe, which
is followed by Asia Pacific. Asia Pacific is the fastest growing market for
Clonorchiasis. Asia Pacific clonorchiasis market is majorly driven by India,
China, and South Korea owing to a huge patient pool, and continuously
developing healthcare sector have fuelled the growth of the market. China has
the largest population of infected people with Clonorchis sinensis. In 2013, over 13 million
people were infected in China.
The Middle East and Africa contribute the least in the
growth of the global clonorchiasis market. However, the Middle East is
dominating the market of this region. The UAE, Saudi Arabia, and Kuwait are
expected to drive the Middle East market. However, Africa holds the least share
of the global market due to limited availability of medical facilities and poor
economic condition. However, the growth of the African market is high due to
the presence of opportunities for the development of the market.
About Market Research Future: At Market Research Future (MRFR), we enable our customers to
unravel the complexity of various industries through our Cooked Research Report
(CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R),
Continuous-Feed Research (CFR), and Market Research & Consulting Services.
MRFR
team have supreme objective to provide the optimum quality market research and
intelligence services to our clients. Our market research studies by products,
services, technologies, applications, end users, and market players for global,
regional, and country level market segments, enable our clients to see more,
know more, and do more, which help to answer all their most important questions.
Contact:
Market
Research Future
Office
No. 524/528, Amanora Chambers
Magarpatta
Road, Hadapsar
Pune -
411028
Maharashtra,
India
+1 646
845 9312
Comments
Post a Comment